1. Home
  2. MOBX vs IXHL Comparison

MOBX vs IXHL Comparison

Compare MOBX & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobix Labs Inc.

MOBX

Mobix Labs Inc.

HOLD

Current Price

$0.86

Market Cap

33.5M

Sector

N/A

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.33

Market Cap

39.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOBX
IXHL
Founded
2020
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
39.0M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
MOBX
IXHL
Price
$0.86
$3.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 6.3M
81.3K
Earning Date
05-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $6,442,000.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 426.31
N/A
52 Week Low
$0.13
$0.16
52 Week High
$4.25
$6.39

Technical Indicators

Market Signals
Indicator
MOBX
IXHL
Relative Strength Index (RSI) 35.85 46.78
Support Level $0.17 $3.10
Resistance Level $1.33 $3.87
Average True Range (ATR) 0.08 0.20
MACD 0.01 -0.03
Stochastic Oscillator 14.48 22.54

Price Performance

Historical Comparison
MOBX
IXHL

About MOBX Mobix Labs Inc.

Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. Its wireless systems solutions include products for RF and millimeter wave (mmWave) communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the defense, aerospace, commercial and industrial sectors. The majority of the company's revenue is derived from product sales to equipment manufacturers. Geographically, it generates the maximum revenue from the United States.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: